Abstract
Tunicates are deliberated to be a rich source of alkaloids, with unique and diverse chemical structures. There are a number of alkaloids derived from marine ascidians and reported to have a variety of pharmacological activities. More than 300 such alkaloids from ascidians have been reported across the globe. In recent years, cancer has become a complicated disease encountered by developing and developed countries around the world. The marine ascidian-derived alkaloids play a potential role in cancer and other diseases. So far, two ascidian-derived alkaloid compounds are commercially available and employed as drugs for the treatment of various cancer in the USA. In other countries, few compounds are under clinical and preclinical trials. This chapter provides detailed information on alkaloids from marine ascidians and the development of these as a promising application in future as anticancer drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahmed AA, Abedalthagafi M (2016) Cancer diagnostics: the journey from histomorphology to molecular profiling. Oncotarget 7(36):58696
Aiello A, Fattorusso E, Imperatore C, Menna M, Müller W (2010) Iodocionin, a cytotoxic iodinated metabolite from the Mediterranean ascidian Ciona edwardsii. Mar Drugs 8(2):285–291
Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández Á (2011) Assessment of the evolution of cancer treatment therapies. Cancers 3(3):3279–3330
Arumugam V, Venkatesan M, Ramachandran S, Sundaresan U (2018) Bioactive peptides from marine ascidians and future drug development – a review. Int J Pept Res Ther 24(1):13–18
Arumugam V, Venkatesan M, Ramachandran K, Ramachandran S, Palanisamy SK, Sundaresan U (2019) Purification, characterization and antibacterial properties of peptide from marine ascidian Didemnum sp. Int J Pept Res Ther:1–8
Berman JJ (2004) Tumor classification: molecular analysis meets Aristotle. BMC Cancer 4(1):10
Bontemps N, Bry D, López-Legentil S, Simon-Levert A, Long C, Banaigs B (2010) Structures and antimicrobial activities of pyridoacridine alkaloids isolated from different chromotypes of the ascidian Cystodytes dellechiajei. J Nat Prod 73(6):1044–1048
Bruneton J (2008) Farmacognosia, 2nd edn. Acribia, Zaragoza. ISBN 978-1-84585-006-7
Chen L, Fu C, Wang G (2017) Microbial diversity associated with ascidians: a review of research methods and application. Symbiosis 71(1):19–26
Chen L, Hu JS, Xu JL, Shao CL, Wang GY (2018) Biological and chemical diversity of ascidian-associated microorganisms. Mar Drugs 16(10):362
Choudhary A, Naughton L, Montánchez I, Dobson A, Rai D (2017) Current status and future prospects of marine natural products (MNPs) as antimicrobials. Mar Drugs 15(9):272
Clement JA, Kitagaki J, Yang Y, Saucedo CJ, O’Keefe BR, Weissman AM, McKee TC, McMahon JB (2008) Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53. Bioorg Med Chem 16(23):10022–10028
Colditz GA, Wei EK (2012) Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 33:137–156
Copp BR, Ireland CM, Barrows LR (1991) Wakayin: a novel cytotoxic pyrroloiminoquinone alkaloid from the ascidian Clavelina species. J Org Chem 56(15):4596–4597
Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta Gen Subj 1830(6):3670–3695
Davis R, Christensen L, Richardson A, Da Rocha R, Ireland C (2003) Rigidin E, a new pyrrolopyrimidine alkaloid from a Papua New Guinea tunicate Eudistoma species. Mar Drugs 1(1):27–33
Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. Microb Biotechnol 4:687–699
Facompré M, Tardy C, Bal-Mahieu C, Colson P, Perez C, Manzanares I, Cuevas C, Bailly C (2003) Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Res 63(21):7392–7399
Foderaro TA, Barrows LR, Lassota P, Ireland CM (1997) Bengacarboline, a new β-carboline from a marine ascidian Didemnum sp. J Org Chem 62(17):6064–6065
França PH, Barbosa DP, da Silva DL, Ribeiro ÊA, Santana AE, Santos BV, Barbosa-Filho JM, Quintans JS, Barreto RS, Quintans-Júnior LJ, Araújo-Júnior JX (2014) Indole alkaloids from marine sources as potential leads against infectious diseases. Biomed Res Int 2014
Gompel M, Leost M, Joffe EB, Puricelli L, Franco LH, Palermo J, Meijer L (2004) Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum. Bioorg Med Chem Lett 14(7):1703–1707
Guittat L, De Cian A, Rosu F, Gabelica V, De Pauw E, Delfourne E, Mergny JL (2005) Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro. Biochim Biophys Acta Gen Subj 1724(3):375–384
Gul W, Hamann MT (2005) Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci 78(5):442–453
Hénon H, Messaoudi S, Anizon F, Aboab B, Kucharczyk N, Léonce S, Golsteyn RM, Pfeiffer B, Prudhomme M (2007) Bis-imide granulatimide analogues as potent checkpoint 1 kinase inhibitors. Eur J Pharmacol 554(2–3):106–112
Henrich CJ, Robey RW, Takada K, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, McMahon JB, Gustafson KR (2009) Botryllamides: natural product inhibitors of ABCG2. ACS Chem Biol 4(8):637–647
Hinck L, Näthke I (2014) Changes in cell and tissue organization in cancer of the breast and colon. Curr Opin Cell Biol 26:87–95
Huang CY, Ju DT, Chang CF, Reddy PM, Velmurugan BK (2017) A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer. Biomedicine 7(4)
Ibrahim SR, Mohamed GA (2016) Marine pyridoacridine alkaloids: biosynthesis and biological activities. Chem Biodivers 13(1):37–47
Ibrahim SR, Mohamed GA (2017) Ingenine E, a new cytotoxic β-carboline alkaloid from the Indonesian sponge Acanthostrongylophoraingens. J Asian Nat Prod Res 19(5):504–509
Imperatore C, Aiello A, D’Aniello F, Senese M, Menna M (2014) Alkaloids from marine invertebrates as important leads for anticancer drugs discovery and development. Molecules 19(12):20391–20423
Isah T (2016) Anticancer alkaloids from trees: development into drugs. Pharmacogn Rev 10(20):90
Jimenez PC, Wilke DV, Ferreira EG, Takeara R, De Moraes MO, Silveira ER, da Cruz Lotufo TM, Lopes NP, Costa-Lotufo LV (2012) Structure elucidation and anticancer activity of 7-oxostaurosporine derivatives from the Brazilian endemic tunicate Eudistoma vannamei. Mar Drugs 10(5):1092–1102
Jimenez PC, Wilke DV, Costa-Lotufo LV (2018) Marine drugs for cancer: surfacing biotechnological innovations from the oceans. Clinics 73
Jin Z (2005) Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep 22(1):111–126
Jin Z (2006) Imidazole, oxazole and thiazole alkaloids. Nat Prod Rep 23(3):464–496
Kang H, Fenical W (1996) Polycarpine dihydrochloride: a cytotoxic dimeric disulfide alkaloid from the Indian Ocean ascidian Polycarpa clavata. Tetrahedron Lett 37(14):2369–2372
Kobayashi J, Cheng J, Walchli MR, Nakamura H, Hirata Y, Sasaki T, Ohizumi Y (1988) Cystodytins A, B, and C, novel tetracyclic aromatic alkaloids with potent antineoplastic activity from the Okinawan tunicate Cystodytes dellechiajei. J Org Chem 53(8):1800–1804
Kobayashi JI, Tsuda M, Tanabe A, Ishibashi M, Cheng JF, Yamamura S, Sasaki T (1991) Cystodytins DI, new cytotoxic tetracyclic aromatic alkaloids from the Okinawan marine tunicate Cystodytes dellechiajei. J Nat Prod 54(6):1634–1638
Lake RJ, Blunt JW, Munro MH (1989) Eudistomins from the New Zealand ascidian Ritterella sigillinoides. Aust J Chem 42(7):1201–1206
Lambert G, Karney RC, Rhee WY, Carman MR (2016) Wild and cultured edible tunicates: a review. Manag Biol Invasions 7(1):59–66
Li Z, Song W, Rubinstein M, Liu D (2018) Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol 11(1):142
Liberio MS, Sadowski MC, Davis RA, Rockstroh A, Vasireddy R, Lehman ML, Nelson CC (2015) The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells. Oncotarget 6(41):43944
Lindequist U (2016) Marine-derived pharmaceuticals–challenges and opportunities. Biomol Ther 24(6):561
Malve H (2016) Exploring the ocean for new drug developments: marine pharmacology. J Pharm Bioallied Sci 8(2):83
Makarieva TN, Dmitrenok AS, Dmitrenok PS, Grebnev BB, Stonik VA (2001) Pibocin B, the first N-O-methylindole marine alkaloid, a metabolite from the Far-Eastern ascidian Eudistoma species. J Nat Prod 64(12):1559–1561
Marco E, Laine W, Tardy C, Lansiaux A, Iwao M, Ishibashi F, Bailly C, Gago F (2005) Molecular determinants of topoisomerase I poisoning by Lamellarins: comparison with Camptothecin and structure− activity relationships. J Med Chem 48(11):3796–3807
Mayer AM, Rodríguez AD, Berlinck RG, Fusetani N (2011) Marine pharmacology in 2007–8: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol 153(2):191–222
Mayer AM, Nguyen M, Kalwajtys P, Kerns H, Newman DJ, Glaser KB (2017) The marine pharmacology and pharmaceuticals pipeline in 2016. FASEB J 31:818–811
Mehbub M, Lei J, Franco C, Zhang W (2014) Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives. Mar Drugs 12(8):4539–4577
Menna M, Fattorusso E, Imperatore C (2011) Alkaloids from marine ascidians. Molecules 16(10):8694–8732
Moquin-Pattey C, Guyot M (1989) Grossularine-1 and grossularine-2, cytotoxic α-carbolines from the tunicate: Dendrodoa grossularia. Tetrahedron 45(11):3445–3450
Oku N, Matsunaga S, Fusetani N (2003) Shishijimicins A−C, novel enediyne antitumor antibiotics from the ascidian Didemnum proliferum. J Am Chem Soc 125(8):2044–2045
Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R (2017) Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One 12(10):e0184360
Rajesh RP, Annappan M (2015) Anticancer effects of brominated indole alkaloid Eudistomin H from marine ascidian (Eudistoma viride) against cervical cancer cells (HeLa). Anticancer Res 35(1):283–293.
Rashid MA, Gustafson KR, Boyd MR (2001) New cytotoxic N-Methylated β-Carboline alkaloids from the marine ascidian Eudistoma gilboverde. J Nat Prod 64(11):1454–1456
Reddy SM, Srinivasulu M, Satyanarayana N, Kondapi AK, Venkateswarlu Y(2005) New potent cytotoxic lamellarin alkaloids from Indian ascidian (Didemnum obscurum).Tetrahedron 61(39):9242–9247
Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Sun F, Li LH, Martin DG (1990) Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J Org Chem 55(15):4512–4515
Sakai R, Rinehart KL, Guan Y, Wang AH (1992) Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo. Proc Natl Acad Sci 89(23):11456–11460
Sasaki T, Ohtani II, Tanaka J, Higa T (1999) Iheyamines, new cytotoxic bisindole pigments from a colonial ascidian, Polycitorella sp. Tetrahedron Lett 40(2):303–306
Schmitz FJ, DeGuzman FS, Hossain MB, Van der Helm D (1991) Cytotoxic aromatic alkaloids from the ascidian Amphicarpa meridiana and Leptoclinides sp.: meridine and 11-hydroxyascididemin. J Org Chem 56(2):804–808
Schupp P, Steube K, Meyer C, Proksch P (2001) Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm. Cancer Lett 174(2):165–172
Segraves NL, Lopez S, Johnson TA, Said SA, Fu X, Schmitz FJ, Pietraszkiewicz H, Valeriote FA, Crews P (2003) Structures and cytotoxicities of fascaplysin and related alkaloids from two marine phyla—Fascaplysinopsis sponges and Didemnum tunicates. Tetrahedron Lett 44(17):3471–3475
Segraves NL, Robinson SJ, Garcia D, Said SA, Fu X, Schmitz FJ, Pietraszkiewicz H, Valeriote FA, Crews P (2004) Comparison of fascaplysin and related alkaloids: a study of structures, cytotoxicities, and sources. J Nat Prod 67(5):783–792
Shenkar N, Swalla BJ (2011) Global diversity of Ascidiacea. PLoS One 6(6):e20657
Shenkar N, Gittenberger A, Lambert G, Rius M, Moreira da Rocha R, Swalla BJ, Turon X (2019) Ascidiacea world database. Accessed at http://www.marinespecies.org/ascidiacea on 2019-05-14. https://doi.org/10.14284/353
Shochet NR, Rudi A, Kashman Y, Hod Y, El-Maghrabi MR, Spector I (1993) Novel marine alkaloids from the tunicate Eudistoma sp. are potent regulators of cellular growth and differentiation and affect cAMP-mediated processes. J Cell Physiol 157(3):481–492
Singh KS, Majik MS (2016) Bioactive alkaloids from marine sponges. In: Marine sponges: chemico-biological and biomedical applications. Springer, New Delhi, pp 257–286
Singh R, Parihar P, Singh M, Bajguz A, Kumar J, Singh S, Singh VP, Prasad SM (2017) Uncovering potential applications of cyanobacteria and algal metabolites in biology, agriculture and medicine: current status and future prospects. Front Microbiol 8:515
Takada K, Imamura N, Gustafson KR, Henrich CJ (2010) Synthesis and structure–activity relationship of botryllamides that block the ABCG2 multidrug transporter. Bioorg Med Chem Lett 20(4):1330–1333
Tardy C, Facompré M, Laine W, Baldeyrou B, Garcı́a-Gravalos D, Francesch A, Mateo C, Pastor A, Jiménez JA, Manzanares I, Cuevas C. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues. Bioorg Med Chem. 2004 12(7):1697-1712.
Tatsuta T, Hosono M, Rotinsulu H, Wewengkang DS, Sumilat DA, Namikoshi M, Yamazaki H (2017) Lissoclibadin 1, a polysulfur aromatic alkaloid from the Indonesian ascidian Lissoclinum cf. badium, induces caspase-dependent apoptosis in human colon cancer cells and suppresses tumor growth in nude mice. J Nat Prod 80(2):499–502
Urban S, Blunt JW, Munro MH (2002) Coproverdine, a novel, cytotoxic marine alkaloid from a New Zealand ascidian. J Nat Prod 65(9):1371–1373
Verbitski SM, Mayne CL, Davis RA, Concepcion GP, Ireland CM (2002) Isolation, structure determination, and biological activity of a novel alkaloid, Perophoramidine, from the Philippine ascidian Perophora namei. J Org Chem 67(20):7124–7126
Watters D (2018) Ascidian toxins with potential for drug development. Mar Drugs 16(5):162
World Health Organization (WHO) (2017) Cancer: fact sheet. http://www.who.int/mediacentre/factsheets/fs297/en/
World Health Organization (2019) World Health Statistics 2019 – World Health Organization. https://www.who.int/health-topics/cancer#tab=tab_1.
Zhang H, Loveridge ST, Tenney K, Crews P (2016) A new 3-alkylpyridine alkaloid from the marine sponge Haliclona sp. and its cytotoxic activity. Nat Prod Res 30(11):1262–1265
Zhang H, Chen J (2018) Current status and future directions of cancer immunotherapy. J Cancer 9(10):1773
Acknowledgment
This work was financially supported by the CSIR-SRF, New Delhi.
Conflict of the Interest
All authors have the no conflict interest.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Venkatesan, M. et al. (2020). Alkaloids from Marine Ascidians (Tunicates) and Potential for Cancer Drug Development. In: Nathani, N.M., Mootapally, C., Gadhvi, I.R., Maitreya, B., Joshi, C.G. (eds) Marine Niche: Applications in Pharmaceutical Sciences . Springer, Singapore. https://doi.org/10.1007/978-981-15-5017-1_15
Download citation
DOI: https://doi.org/10.1007/978-981-15-5017-1_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5016-4
Online ISBN: 978-981-15-5017-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)